This today in BioSpace: Good article Nearly
Post# of 157844

Nearly Three Quarters of FDA Breakthrough Designated Drugs Win Approval: Report
New analysis from Jefferies shows that rare disease and cancer drugs granted the status are especially likely to be approved.
https://www.biospace.com/fda/nearly-three-qua...val-report

